Global Artemisinin Combination Therapy Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Artemisinin Combination Therapy market size was valued at US$ 340.4 million in 2023. With growing demand in downstream market, the Artemisinin Combination Therapy is forecast to a readjusted size of US$ 478.3 million by 2030 with a CAGR of 5.0% during review period.
The research report highlights the growth potential of the global Artemisinin Combination Therapy market. Artemisinin Combination Therapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Artemisinin Combination Therapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Artemisinin Combination Therapy market.
Artemisinin Combination Therapy is recommended for thetreatment of P. falciparum malaria. Fast acting artemisinin-based compounds arecombined with a drug from a different class and artemisinin derivatives include dihydroartemisinin, artesunate and artemether.
Key Features:
The report on Artemisinin Combination Therapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Artemisinin Combination Therapy market. It may include historical data, market segmentation by Type (e.g., Artemether+Lumefantrine, Artesunate+Amodiaquine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Artemisinin Combination Therapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Artemisinin Combination Therapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Artemisinin Combination Therapy industry. This include advancements in Artemisinin Combination Therapy technology, Artemisinin Combination Therapy new entrants, Artemisinin Combination Therapy new investment, and other innovations that are shaping the future of Artemisinin Combination Therapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Artemisinin Combination Therapy market. It includes factors influencing customer ' purchasing decisions, preferences for Artemisinin Combination Therapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Artemisinin Combination Therapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Artemisinin Combination Therapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Artemisinin Combination Therapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Artemisinin Combination Therapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Artemisinin Combination Therapy market.
Market Segmentation:
Artemisinin Combination Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Artemisinin Combination Therapy market size was valued at US$ 340.4 million in 2023. With growing demand in downstream market, the Artemisinin Combination Therapy is forecast to a readjusted size of US$ 478.3 million by 2030 with a CAGR of 5.0% during review period.
The research report highlights the growth potential of the global Artemisinin Combination Therapy market. Artemisinin Combination Therapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Artemisinin Combination Therapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Artemisinin Combination Therapy market.
Artemisinin Combination Therapy is recommended for thetreatment of P. falciparum malaria. Fast acting artemisinin-based compounds arecombined with a drug from a different class and artemisinin derivatives include dihydroartemisinin, artesunate and artemether.
Key Features:
The report on Artemisinin Combination Therapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Artemisinin Combination Therapy market. It may include historical data, market segmentation by Type (e.g., Artemether+Lumefantrine, Artesunate+Amodiaquine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Artemisinin Combination Therapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Artemisinin Combination Therapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Artemisinin Combination Therapy industry. This include advancements in Artemisinin Combination Therapy technology, Artemisinin Combination Therapy new entrants, Artemisinin Combination Therapy new investment, and other innovations that are shaping the future of Artemisinin Combination Therapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Artemisinin Combination Therapy market. It includes factors influencing customer ' purchasing decisions, preferences for Artemisinin Combination Therapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Artemisinin Combination Therapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Artemisinin Combination Therapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Artemisinin Combination Therapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Artemisinin Combination Therapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Artemisinin Combination Therapy market.
Market Segmentation:
Artemisinin Combination Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Artemether+Lumefantrine
- Artesunate+Amodiaquine
- Dihydroartemisinin+Piperaquine
- Artesunate+Mefloquine
- Artesunate+Sulfadoxine-Pyrimethamine
- Pyronaridine-Artesunate
- Other
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- KPC Pharmaceuticals
- Shanghai Fosun Pharmaceutical Industrial Development
- Sanofi
- Desano Holdings
- Calyx Chemicals and Pharmaceuticals
- Mylan
- Novartis
- Denk Pharma
- Hovid Berhad
- Ipca Laboratories
- Cipla
- Aspen Pharmacare Holdings
- Ajanta Pharma
- Guilin Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artemisinin Combination Therapy Market Size 2019-2030
2.1.2 Artemisinin Combination Therapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Artemisinin Combination Therapy Segment by Type
2.2.1 Artemether+Lumefantrine
2.2.2 Artesunate+Amodiaquine
2.2.3 Dihydroartemisinin+Piperaquine
2.2.4 Artesunate+Mefloquine
2.2.5 Artesunate+Sulfadoxine-Pyrimethamine
2.2.6 Pyronaridine-Artesunate
2.2.7 Other
2.3 Artemisinin Combination Therapy Market Size by Type
2.3.1 Artemisinin Combination Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Artemisinin Combination Therapy Market Size Market Share by Type (2019-2024)
2.4 Artemisinin Combination Therapy Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Artemisinin Combination Therapy Market Size by Application
2.5.1 Artemisinin Combination Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Artemisinin Combination Therapy Market Size Market Share by Application (2019-2024)
3 ARTEMISININ COMBINATION THERAPY MARKET SIZE BY PLAYER
3.1 Artemisinin Combination Therapy Market Size Market Share by Players
3.1.1 Global Artemisinin Combination Therapy Revenue by Players (2019-2024)
3.1.2 Global Artemisinin Combination Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Artemisinin Combination Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ARTEMISININ COMBINATION THERAPY BY REGIONS
4.1 Artemisinin Combination Therapy Market Size by Regions (2019-2024)
4.2 Americas Artemisinin Combination Therapy Market Size Growth (2019-2024)
4.3 APAC Artemisinin Combination Therapy Market Size Growth (2019-2024)
4.4 Europe Artemisinin Combination Therapy Market Size Growth (2019-2024)
4.5 Middle East & Africa Artemisinin Combination Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Artemisinin Combination Therapy Market Size by Country (2019-2024)
5.2 Americas Artemisinin Combination Therapy Market Size by Type (2019-2024)
5.3 Americas Artemisinin Combination Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artemisinin Combination Therapy Market Size by Region (2019-2024)
6.2 APAC Artemisinin Combination Therapy Market Size by Type (2019-2024)
6.3 APAC Artemisinin Combination Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Artemisinin Combination Therapy by Country (2019-2024)
7.2 Europe Artemisinin Combination Therapy Market Size by Type (2019-2024)
7.3 Europe Artemisinin Combination Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artemisinin Combination Therapy by Region (2019-2024)
8.2 Middle East & Africa Artemisinin Combination Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Artemisinin Combination Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ARTEMISININ COMBINATION THERAPY MARKET FORECAST
10.1 Global Artemisinin Combination Therapy Forecast by Regions (2025-2030)
10.1.1 Global Artemisinin Combination Therapy Forecast by Regions (2025-2030)
10.1.2 Americas Artemisinin Combination Therapy Forecast
10.1.3 APAC Artemisinin Combination Therapy Forecast
10.1.4 Europe Artemisinin Combination Therapy Forecast
10.1.5 Middle East & Africa Artemisinin Combination Therapy Forecast
10.2 Americas Artemisinin Combination Therapy Forecast by Country (2025-2030)
10.2.1 United States Artemisinin Combination Therapy Market Forecast
10.2.2 Canada Artemisinin Combination Therapy Market Forecast
10.2.3 Mexico Artemisinin Combination Therapy Market Forecast
10.2.4 Brazil Artemisinin Combination Therapy Market Forecast
10.3 APAC Artemisinin Combination Therapy Forecast by Region (2025-2030)
10.3.1 China Artemisinin Combination Therapy Market Forecast
10.3.2 Japan Artemisinin Combination Therapy Market Forecast
10.3.3 Korea Artemisinin Combination Therapy Market Forecast
10.3.4 Southeast Asia Artemisinin Combination Therapy Market Forecast
10.3.5 India Artemisinin Combination Therapy Market Forecast
10.3.6 Australia Artemisinin Combination Therapy Market Forecast
10.4 Europe Artemisinin Combination Therapy Forecast by Country (2025-2030)
10.4.1 Germany Artemisinin Combination Therapy Market Forecast
10.4.2 France Artemisinin Combination Therapy Market Forecast
10.4.3 UK Artemisinin Combination Therapy Market Forecast
10.4.4 Italy Artemisinin Combination Therapy Market Forecast
10.4.5 Russia Artemisinin Combination Therapy Market Forecast
10.5 Middle East & Africa Artemisinin Combination Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Artemisinin Combination Therapy Market Forecast
10.5.2 South Africa Artemisinin Combination Therapy Market Forecast
10.5.3 Israel Artemisinin Combination Therapy Market Forecast
10.5.4 Turkey Artemisinin Combination Therapy Market Forecast
10.5.5 GCC Countries Artemisinin Combination Therapy Market Forecast
10.6 Global Artemisinin Combination Therapy Forecast by Type (2025-2030)
10.7 Global Artemisinin Combination Therapy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 KPC Pharmaceuticals
11.1.1 KPC Pharmaceuticals Company Information
11.1.2 KPC Pharmaceuticals Artemisinin Combination Therapy Product Offered
11.1.3 KPC Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 KPC Pharmaceuticals Main Business Overview
11.1.5 KPC Pharmaceuticals Latest Developments
11.2 Shanghai Fosun Pharmaceutical Industrial Development
11.2.1 Shanghai Fosun Pharmaceutical Industrial Development Company Information
11.2.2 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product Offered
11.2.3 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Shanghai Fosun Pharmaceutical Industrial Development Main Business Overview
11.2.5 Shanghai Fosun Pharmaceutical Industrial Development Latest Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Artemisinin Combination Therapy Product Offered
11.3.3 Sanofi Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Sanofi Main Business Overview
11.3.5 Sanofi Latest Developments
11.4 Desano Holdings
11.4.1 Desano Holdings Company Information
11.4.2 Desano Holdings Artemisinin Combination Therapy Product Offered
11.4.3 Desano Holdings Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Desano Holdings Main Business Overview
11.4.5 Desano Holdings Latest Developments
11.5 Calyx Chemicals and Pharmaceuticals
11.5.1 Calyx Chemicals and Pharmaceuticals Company Information
11.5.2 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product Offered
11.5.3 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Calyx Chemicals and Pharmaceuticals Main Business Overview
11.5.5 Calyx Chemicals and Pharmaceuticals Latest Developments
11.6 Mylan
11.6.1 Mylan Company Information
11.6.2 Mylan Artemisinin Combination Therapy Product Offered
11.6.3 Mylan Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Mylan Main Business Overview
11.6.5 Mylan Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Artemisinin Combination Therapy Product Offered
11.7.3 Novartis Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 Denk Pharma
11.8.1 Denk Pharma Company Information
11.8.2 Denk Pharma Artemisinin Combination Therapy Product Offered
11.8.3 Denk Pharma Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Denk Pharma Main Business Overview
11.8.5 Denk Pharma Latest Developments
11.9 Hovid Berhad
11.9.1 Hovid Berhad Company Information
11.9.2 Hovid Berhad Artemisinin Combination Therapy Product Offered
11.9.3 Hovid Berhad Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Hovid Berhad Main Business Overview
11.9.5 Hovid Berhad Latest Developments
11.10 Ipca Laboratories
11.10.1 Ipca Laboratories Company Information
11.10.2 Ipca Laboratories Artemisinin Combination Therapy Product Offered
11.10.3 Ipca Laboratories Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Ipca Laboratories Main Business Overview
11.10.5 Ipca Laboratories Latest Developments
11.11 Cipla
11.11.1 Cipla Company Information
11.11.2 Cipla Artemisinin Combination Therapy Product Offered
11.11.3 Cipla Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Cipla Main Business Overview
11.11.5 Cipla Latest Developments
11.12 Aspen Pharmacare Holdings
11.12.1 Aspen Pharmacare Holdings Company Information
11.12.2 Aspen Pharmacare Holdings Artemisinin Combination Therapy Product Offered
11.12.3 Aspen Pharmacare Holdings Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Aspen Pharmacare Holdings Main Business Overview
11.12.5 Aspen Pharmacare Holdings Latest Developments
11.13 Ajanta Pharma
11.13.1 Ajanta Pharma Company Information
11.13.2 Ajanta Pharma Artemisinin Combination Therapy Product Offered
11.13.3 Ajanta Pharma Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Ajanta Pharma Main Business Overview
11.13.5 Ajanta Pharma Latest Developments
11.14 Guilin Pharmaceuticals
11.14.1 Guilin Pharmaceuticals Company Information
11.14.2 Guilin Pharmaceuticals Artemisinin Combination Therapy Product Offered
11.14.3 Guilin Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Guilin Pharmaceuticals Main Business Overview
11.14.5 Guilin Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artemisinin Combination Therapy Market Size 2019-2030
2.1.2 Artemisinin Combination Therapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Artemisinin Combination Therapy Segment by Type
2.2.1 Artemether+Lumefantrine
2.2.2 Artesunate+Amodiaquine
2.2.3 Dihydroartemisinin+Piperaquine
2.2.4 Artesunate+Mefloquine
2.2.5 Artesunate+Sulfadoxine-Pyrimethamine
2.2.6 Pyronaridine-Artesunate
2.2.7 Other
2.3 Artemisinin Combination Therapy Market Size by Type
2.3.1 Artemisinin Combination Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Artemisinin Combination Therapy Market Size Market Share by Type (2019-2024)
2.4 Artemisinin Combination Therapy Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Artemisinin Combination Therapy Market Size by Application
2.5.1 Artemisinin Combination Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Artemisinin Combination Therapy Market Size Market Share by Application (2019-2024)
3 ARTEMISININ COMBINATION THERAPY MARKET SIZE BY PLAYER
3.1 Artemisinin Combination Therapy Market Size Market Share by Players
3.1.1 Global Artemisinin Combination Therapy Revenue by Players (2019-2024)
3.1.2 Global Artemisinin Combination Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Artemisinin Combination Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ARTEMISININ COMBINATION THERAPY BY REGIONS
4.1 Artemisinin Combination Therapy Market Size by Regions (2019-2024)
4.2 Americas Artemisinin Combination Therapy Market Size Growth (2019-2024)
4.3 APAC Artemisinin Combination Therapy Market Size Growth (2019-2024)
4.4 Europe Artemisinin Combination Therapy Market Size Growth (2019-2024)
4.5 Middle East & Africa Artemisinin Combination Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Artemisinin Combination Therapy Market Size by Country (2019-2024)
5.2 Americas Artemisinin Combination Therapy Market Size by Type (2019-2024)
5.3 Americas Artemisinin Combination Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artemisinin Combination Therapy Market Size by Region (2019-2024)
6.2 APAC Artemisinin Combination Therapy Market Size by Type (2019-2024)
6.3 APAC Artemisinin Combination Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Artemisinin Combination Therapy by Country (2019-2024)
7.2 Europe Artemisinin Combination Therapy Market Size by Type (2019-2024)
7.3 Europe Artemisinin Combination Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artemisinin Combination Therapy by Region (2019-2024)
8.2 Middle East & Africa Artemisinin Combination Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Artemisinin Combination Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ARTEMISININ COMBINATION THERAPY MARKET FORECAST
10.1 Global Artemisinin Combination Therapy Forecast by Regions (2025-2030)
10.1.1 Global Artemisinin Combination Therapy Forecast by Regions (2025-2030)
10.1.2 Americas Artemisinin Combination Therapy Forecast
10.1.3 APAC Artemisinin Combination Therapy Forecast
10.1.4 Europe Artemisinin Combination Therapy Forecast
10.1.5 Middle East & Africa Artemisinin Combination Therapy Forecast
10.2 Americas Artemisinin Combination Therapy Forecast by Country (2025-2030)
10.2.1 United States Artemisinin Combination Therapy Market Forecast
10.2.2 Canada Artemisinin Combination Therapy Market Forecast
10.2.3 Mexico Artemisinin Combination Therapy Market Forecast
10.2.4 Brazil Artemisinin Combination Therapy Market Forecast
10.3 APAC Artemisinin Combination Therapy Forecast by Region (2025-2030)
10.3.1 China Artemisinin Combination Therapy Market Forecast
10.3.2 Japan Artemisinin Combination Therapy Market Forecast
10.3.3 Korea Artemisinin Combination Therapy Market Forecast
10.3.4 Southeast Asia Artemisinin Combination Therapy Market Forecast
10.3.5 India Artemisinin Combination Therapy Market Forecast
10.3.6 Australia Artemisinin Combination Therapy Market Forecast
10.4 Europe Artemisinin Combination Therapy Forecast by Country (2025-2030)
10.4.1 Germany Artemisinin Combination Therapy Market Forecast
10.4.2 France Artemisinin Combination Therapy Market Forecast
10.4.3 UK Artemisinin Combination Therapy Market Forecast
10.4.4 Italy Artemisinin Combination Therapy Market Forecast
10.4.5 Russia Artemisinin Combination Therapy Market Forecast
10.5 Middle East & Africa Artemisinin Combination Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Artemisinin Combination Therapy Market Forecast
10.5.2 South Africa Artemisinin Combination Therapy Market Forecast
10.5.3 Israel Artemisinin Combination Therapy Market Forecast
10.5.4 Turkey Artemisinin Combination Therapy Market Forecast
10.5.5 GCC Countries Artemisinin Combination Therapy Market Forecast
10.6 Global Artemisinin Combination Therapy Forecast by Type (2025-2030)
10.7 Global Artemisinin Combination Therapy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 KPC Pharmaceuticals
11.1.1 KPC Pharmaceuticals Company Information
11.1.2 KPC Pharmaceuticals Artemisinin Combination Therapy Product Offered
11.1.3 KPC Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 KPC Pharmaceuticals Main Business Overview
11.1.5 KPC Pharmaceuticals Latest Developments
11.2 Shanghai Fosun Pharmaceutical Industrial Development
11.2.1 Shanghai Fosun Pharmaceutical Industrial Development Company Information
11.2.2 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product Offered
11.2.3 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Shanghai Fosun Pharmaceutical Industrial Development Main Business Overview
11.2.5 Shanghai Fosun Pharmaceutical Industrial Development Latest Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Artemisinin Combination Therapy Product Offered
11.3.3 Sanofi Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Sanofi Main Business Overview
11.3.5 Sanofi Latest Developments
11.4 Desano Holdings
11.4.1 Desano Holdings Company Information
11.4.2 Desano Holdings Artemisinin Combination Therapy Product Offered
11.4.3 Desano Holdings Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Desano Holdings Main Business Overview
11.4.5 Desano Holdings Latest Developments
11.5 Calyx Chemicals and Pharmaceuticals
11.5.1 Calyx Chemicals and Pharmaceuticals Company Information
11.5.2 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product Offered
11.5.3 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Calyx Chemicals and Pharmaceuticals Main Business Overview
11.5.5 Calyx Chemicals and Pharmaceuticals Latest Developments
11.6 Mylan
11.6.1 Mylan Company Information
11.6.2 Mylan Artemisinin Combination Therapy Product Offered
11.6.3 Mylan Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Mylan Main Business Overview
11.6.5 Mylan Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Artemisinin Combination Therapy Product Offered
11.7.3 Novartis Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 Denk Pharma
11.8.1 Denk Pharma Company Information
11.8.2 Denk Pharma Artemisinin Combination Therapy Product Offered
11.8.3 Denk Pharma Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Denk Pharma Main Business Overview
11.8.5 Denk Pharma Latest Developments
11.9 Hovid Berhad
11.9.1 Hovid Berhad Company Information
11.9.2 Hovid Berhad Artemisinin Combination Therapy Product Offered
11.9.3 Hovid Berhad Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Hovid Berhad Main Business Overview
11.9.5 Hovid Berhad Latest Developments
11.10 Ipca Laboratories
11.10.1 Ipca Laboratories Company Information
11.10.2 Ipca Laboratories Artemisinin Combination Therapy Product Offered
11.10.3 Ipca Laboratories Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Ipca Laboratories Main Business Overview
11.10.5 Ipca Laboratories Latest Developments
11.11 Cipla
11.11.1 Cipla Company Information
11.11.2 Cipla Artemisinin Combination Therapy Product Offered
11.11.3 Cipla Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Cipla Main Business Overview
11.11.5 Cipla Latest Developments
11.12 Aspen Pharmacare Holdings
11.12.1 Aspen Pharmacare Holdings Company Information
11.12.2 Aspen Pharmacare Holdings Artemisinin Combination Therapy Product Offered
11.12.3 Aspen Pharmacare Holdings Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Aspen Pharmacare Holdings Main Business Overview
11.12.5 Aspen Pharmacare Holdings Latest Developments
11.13 Ajanta Pharma
11.13.1 Ajanta Pharma Company Information
11.13.2 Ajanta Pharma Artemisinin Combination Therapy Product Offered
11.13.3 Ajanta Pharma Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Ajanta Pharma Main Business Overview
11.13.5 Ajanta Pharma Latest Developments
11.14 Guilin Pharmaceuticals
11.14.1 Guilin Pharmaceuticals Company Information
11.14.2 Guilin Pharmaceuticals Artemisinin Combination Therapy Product Offered
11.14.3 Guilin Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Guilin Pharmaceuticals Main Business Overview
11.14.5 Guilin Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Artemisinin Combination Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Artemether+Lumefantrine
Table 3. Major Players of Artesunate+Amodiaquine
Table 4. Major Players of Dihydroartemisinin+Piperaquine
Table 5. Major Players of Artesunate+Mefloquine
Table 6. Major Players of Artesunate+Sulfadoxine-Pyrimethamine
Table 7. Major Players of Pyronaridine-Artesunate
Table 8. Major Players of Other
Table 9. Artemisinin Combination Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Artemisinin Combination Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 11. Global Artemisinin Combination Therapy Market Size Market Share by Type (2019-2024)
Table 12. Artemisinin Combination Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 13. Global Artemisinin Combination Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 14. Global Artemisinin Combination Therapy Market Size Market Share by Application (2019-2024)
Table 15. Global Artemisinin Combination Therapy Revenue by Players (2019-2024) & ($ Millions)
Table 16. Global Artemisinin Combination Therapy Revenue Market Share by Player (2019-2024)
Table 17. Artemisinin Combination Therapy Key Players Head office and Products Offered
Table 18. Artemisinin Combination Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Artemisinin Combination Therapy Market Size by Regions 2019-2024 & ($ Millions)
Table 22. Global Artemisinin Combination Therapy Market Size Market Share by Regions (2019-2024)
Table 23. Global Artemisinin Combination Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 24. Global Artemisinin Combination Therapy Revenue Market Share by Country/Region (2019-2024)
Table 25. Americas Artemisinin Combination Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 26. Americas Artemisinin Combination Therapy Market Size Market Share by Country (2019-2024)
Table 27. Americas Artemisinin Combination Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 28. Americas Artemisinin Combination Therapy Market Size Market Share by Type (2019-2024)
Table 29. Americas Artemisinin Combination Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 30. Americas Artemisinin Combination Therapy Market Size Market Share by Application (2019-2024)
Table 31. APAC Artemisinin Combination Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 32. APAC Artemisinin Combination Therapy Market Size Market Share by Region (2019-2024)
Table 33. APAC Artemisinin Combination Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 34. APAC Artemisinin Combination Therapy Market Size Market Share by Type (2019-2024)
Table 35. APAC Artemisinin Combination Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 36. APAC Artemisinin Combination Therapy Market Size Market Share by Application (2019-2024)
Table 37. Europe Artemisinin Combination Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 38. Europe Artemisinin Combination Therapy Market Size Market Share by Country (2019-2024)
Table 39. Europe Artemisinin Combination Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 40. Europe Artemisinin Combination Therapy Market Size Market Share by Type (2019-2024)
Table 41. Europe Artemisinin Combination Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 42. Europe Artemisinin Combination Therapy Market Size Market Share by Application (2019-2024)
Table 43. Middle East & Africa Artemisinin Combination Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Region (2019-2024)
Table 45. Middle East & Africa Artemisinin Combination Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Type (2019-2024)
Table 47. Middle East & Africa Artemisinin Combination Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 48. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Application (2019-2024)
Table 49. Key Market Drivers & Growth Opportunities of Artemisinin Combination Therapy
Table 50. Key Market Challenges & Risks of Artemisinin Combination Therapy
Table 51. Key Industry Trends of Artemisinin Combination Therapy
Table 52. Global Artemisinin Combination Therapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 53. Global Artemisinin Combination Therapy Market Size Market Share Forecast by Regions (2025-2030)
Table 54. Global Artemisinin Combination Therapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 55. Global Artemisinin Combination Therapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 56. KPC Pharmaceuticals Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 57. KPC Pharmaceuticals Artemisinin Combination Therapy Product Offered
Table 58. KPC Pharmaceuticals Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. KPC Pharmaceuticals Main Business
Table 60. KPC Pharmaceuticals Latest Developments
Table 61. Shanghai Fosun Pharmaceutical Industrial Development Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 62. Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product Offered
Table 63. Shanghai Fosun Pharmaceutical Industrial Development Main Business
Table 64. Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Shanghai Fosun Pharmaceutical Industrial Development Latest Developments
Table 66. Sanofi Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 67. Sanofi Artemisinin Combination Therapy Product Offered
Table 68. Sanofi Main Business
Table 69. Sanofi Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Sanofi Latest Developments
Table 71. Desano Holdings Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 72. Desano Holdings Artemisinin Combination Therapy Product Offered
Table 73. Desano Holdings Main Business
Table 74. Desano Holdings Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Desano Holdings Latest Developments
Table 76. Calyx Chemicals and Pharmaceuticals Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 77. Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product Offered
Table 78. Calyx Chemicals and Pharmaceuticals Main Business
Table 79. Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Calyx Chemicals and Pharmaceuticals Latest Developments
Table 81. Mylan Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 82. Mylan Artemisinin Combination Therapy Product Offered
Table 83. Mylan Main Business
Table 84. Mylan Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Mylan Latest Developments
Table 86. Novartis Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 87. Novartis Artemisinin Combination Therapy Product Offered
Table 88. Novartis Main Business
Table 89. Novartis Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Novartis Latest Developments
Table 91. Denk Pharma Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 92. Denk Pharma Artemisinin Combination Therapy Product Offered
Table 93. Denk Pharma Main Business
Table 94. Denk Pharma Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Denk Pharma Latest Developments
Table 96. Hovid Berhad Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 97. Hovid Berhad Artemisinin Combination Therapy Product Offered
Table 98. Hovid Berhad Main Business
Table 99. Hovid Berhad Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Hovid Berhad Latest Developments
Table 101. Ipca Laboratories Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 102. Ipca Laboratories Artemisinin Combination Therapy Product Offered
Table 103. Ipca Laboratories Main Business
Table 104. Ipca Laboratories Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Ipca Laboratories Latest Developments
Table 106. Cipla Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 107. Cipla Artemisinin Combination Therapy Product Offered
Table 108. Cipla Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 109. Cipla Main Business
Table 110. Cipla Latest Developments
Table 111. Aspen Pharmacare Holdings Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 112. Aspen Pharmacare Holdings Artemisinin Combination Therapy Product Offered
Table 113. Aspen Pharmacare Holdings Main Business
Table 114. Aspen Pharmacare Holdings Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Aspen Pharmacare Holdings Latest Developments
Table 116. Ajanta Pharma Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 117. Ajanta Pharma Artemisinin Combination Therapy Product Offered
Table 118. Ajanta Pharma Main Business
Table 119. Ajanta Pharma Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Ajanta Pharma Latest Developments
Table 121. Guilin Pharmaceuticals Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 122. Guilin Pharmaceuticals Artemisinin Combination Therapy Product Offered
Table 123. Guilin Pharmaceuticals Main Business
Table 124. Guilin Pharmaceuticals Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Guilin Pharmaceuticals Latest Developments
Table 1. Artemisinin Combination Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Artemether+Lumefantrine
Table 3. Major Players of Artesunate+Amodiaquine
Table 4. Major Players of Dihydroartemisinin+Piperaquine
Table 5. Major Players of Artesunate+Mefloquine
Table 6. Major Players of Artesunate+Sulfadoxine-Pyrimethamine
Table 7. Major Players of Pyronaridine-Artesunate
Table 8. Major Players of Other
Table 9. Artemisinin Combination Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Artemisinin Combination Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 11. Global Artemisinin Combination Therapy Market Size Market Share by Type (2019-2024)
Table 12. Artemisinin Combination Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 13. Global Artemisinin Combination Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 14. Global Artemisinin Combination Therapy Market Size Market Share by Application (2019-2024)
Table 15. Global Artemisinin Combination Therapy Revenue by Players (2019-2024) & ($ Millions)
Table 16. Global Artemisinin Combination Therapy Revenue Market Share by Player (2019-2024)
Table 17. Artemisinin Combination Therapy Key Players Head office and Products Offered
Table 18. Artemisinin Combination Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Artemisinin Combination Therapy Market Size by Regions 2019-2024 & ($ Millions)
Table 22. Global Artemisinin Combination Therapy Market Size Market Share by Regions (2019-2024)
Table 23. Global Artemisinin Combination Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 24. Global Artemisinin Combination Therapy Revenue Market Share by Country/Region (2019-2024)
Table 25. Americas Artemisinin Combination Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 26. Americas Artemisinin Combination Therapy Market Size Market Share by Country (2019-2024)
Table 27. Americas Artemisinin Combination Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 28. Americas Artemisinin Combination Therapy Market Size Market Share by Type (2019-2024)
Table 29. Americas Artemisinin Combination Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 30. Americas Artemisinin Combination Therapy Market Size Market Share by Application (2019-2024)
Table 31. APAC Artemisinin Combination Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 32. APAC Artemisinin Combination Therapy Market Size Market Share by Region (2019-2024)
Table 33. APAC Artemisinin Combination Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 34. APAC Artemisinin Combination Therapy Market Size Market Share by Type (2019-2024)
Table 35. APAC Artemisinin Combination Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 36. APAC Artemisinin Combination Therapy Market Size Market Share by Application (2019-2024)
Table 37. Europe Artemisinin Combination Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 38. Europe Artemisinin Combination Therapy Market Size Market Share by Country (2019-2024)
Table 39. Europe Artemisinin Combination Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 40. Europe Artemisinin Combination Therapy Market Size Market Share by Type (2019-2024)
Table 41. Europe Artemisinin Combination Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 42. Europe Artemisinin Combination Therapy Market Size Market Share by Application (2019-2024)
Table 43. Middle East & Africa Artemisinin Combination Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Region (2019-2024)
Table 45. Middle East & Africa Artemisinin Combination Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Type (2019-2024)
Table 47. Middle East & Africa Artemisinin Combination Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 48. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Application (2019-2024)
Table 49. Key Market Drivers & Growth Opportunities of Artemisinin Combination Therapy
Table 50. Key Market Challenges & Risks of Artemisinin Combination Therapy
Table 51. Key Industry Trends of Artemisinin Combination Therapy
Table 52. Global Artemisinin Combination Therapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 53. Global Artemisinin Combination Therapy Market Size Market Share Forecast by Regions (2025-2030)
Table 54. Global Artemisinin Combination Therapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 55. Global Artemisinin Combination Therapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 56. KPC Pharmaceuticals Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 57. KPC Pharmaceuticals Artemisinin Combination Therapy Product Offered
Table 58. KPC Pharmaceuticals Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. KPC Pharmaceuticals Main Business
Table 60. KPC Pharmaceuticals Latest Developments
Table 61. Shanghai Fosun Pharmaceutical Industrial Development Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 62. Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product Offered
Table 63. Shanghai Fosun Pharmaceutical Industrial Development Main Business
Table 64. Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Shanghai Fosun Pharmaceutical Industrial Development Latest Developments
Table 66. Sanofi Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 67. Sanofi Artemisinin Combination Therapy Product Offered
Table 68. Sanofi Main Business
Table 69. Sanofi Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Sanofi Latest Developments
Table 71. Desano Holdings Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 72. Desano Holdings Artemisinin Combination Therapy Product Offered
Table 73. Desano Holdings Main Business
Table 74. Desano Holdings Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Desano Holdings Latest Developments
Table 76. Calyx Chemicals and Pharmaceuticals Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 77. Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product Offered
Table 78. Calyx Chemicals and Pharmaceuticals Main Business
Table 79. Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Calyx Chemicals and Pharmaceuticals Latest Developments
Table 81. Mylan Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 82. Mylan Artemisinin Combination Therapy Product Offered
Table 83. Mylan Main Business
Table 84. Mylan Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Mylan Latest Developments
Table 86. Novartis Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 87. Novartis Artemisinin Combination Therapy Product Offered
Table 88. Novartis Main Business
Table 89. Novartis Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Novartis Latest Developments
Table 91. Denk Pharma Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 92. Denk Pharma Artemisinin Combination Therapy Product Offered
Table 93. Denk Pharma Main Business
Table 94. Denk Pharma Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Denk Pharma Latest Developments
Table 96. Hovid Berhad Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 97. Hovid Berhad Artemisinin Combination Therapy Product Offered
Table 98. Hovid Berhad Main Business
Table 99. Hovid Berhad Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Hovid Berhad Latest Developments
Table 101. Ipca Laboratories Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 102. Ipca Laboratories Artemisinin Combination Therapy Product Offered
Table 103. Ipca Laboratories Main Business
Table 104. Ipca Laboratories Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Ipca Laboratories Latest Developments
Table 106. Cipla Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 107. Cipla Artemisinin Combination Therapy Product Offered
Table 108. Cipla Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 109. Cipla Main Business
Table 110. Cipla Latest Developments
Table 111. Aspen Pharmacare Holdings Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 112. Aspen Pharmacare Holdings Artemisinin Combination Therapy Product Offered
Table 113. Aspen Pharmacare Holdings Main Business
Table 114. Aspen Pharmacare Holdings Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Aspen Pharmacare Holdings Latest Developments
Table 116. Ajanta Pharma Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 117. Ajanta Pharma Artemisinin Combination Therapy Product Offered
Table 118. Ajanta Pharma Main Business
Table 119. Ajanta Pharma Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Ajanta Pharma Latest Developments
Table 121. Guilin Pharmaceuticals Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 122. Guilin Pharmaceuticals Artemisinin Combination Therapy Product Offered
Table 123. Guilin Pharmaceuticals Main Business
Table 124. Guilin Pharmaceuticals Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Guilin Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Artemisinin Combination Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Artemisinin Combination Therapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Artemisinin Combination Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Artemisinin Combination Therapy Sales Market Share by Country/Region (2023)
Figure 8. Artemisinin Combination Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Artemisinin Combination Therapy Market Size Market Share by Type in 2023
Figure 10. Artemisinin Combination Therapy in Hospital
Figure 11. Global Artemisinin Combination Therapy Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Artemisinin Combination Therapy in Clinic
Figure 13. Global Artemisinin Combination Therapy Market: Clinic (2019-2024) & ($ Millions)
Figure 14. Artemisinin Combination Therapy in Other
Figure 15. Global Artemisinin Combination Therapy Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Artemisinin Combination Therapy Market Size Market Share by Application in 2023
Figure 17. Global Artemisinin Combination Therapy Revenue Market Share by Player in 2023
Figure 18. Global Artemisinin Combination Therapy Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure 20. APAC Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure 21. Europe Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure 23. Americas Artemisinin Combination Therapy Value Market Share by Country in 2023
Figure 24. United States Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Artemisinin Combination Therapy Market Size Market Share by Region in 2023
Figure 29. APAC Artemisinin Combination Therapy Market Size Market Share by Type in 2023
Figure 30. APAC Artemisinin Combination Therapy Market Size Market Share by Application in 2023
Figure 31. China Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Artemisinin Combination Therapy Market Size Market Share by Country in 2023
Figure 38. Europe Artemisinin Combination Therapy Market Size Market Share by Type (2019-2024)
Figure 39. Europe Artemisinin Combination Therapy Market Size Market Share by Application (2019-2024)
Figure 40. Germany Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 54. APAC Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 55. Europe Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 57. United States Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 58. Canada Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 61. China Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 62. Japan Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 63. Korea Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 65. India Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 66. Australia Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 67. Germany Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 68. France Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 69. UK Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 70. Italy Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 71. Russia Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 72. Spain Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 75. Israel Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 78. Global Artemisinin Combination Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Artemisinin Combination Therapy Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Artemisinin Combination Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Artemisinin Combination Therapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Artemisinin Combination Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Artemisinin Combination Therapy Sales Market Share by Country/Region (2023)
Figure 8. Artemisinin Combination Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Artemisinin Combination Therapy Market Size Market Share by Type in 2023
Figure 10. Artemisinin Combination Therapy in Hospital
Figure 11. Global Artemisinin Combination Therapy Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Artemisinin Combination Therapy in Clinic
Figure 13. Global Artemisinin Combination Therapy Market: Clinic (2019-2024) & ($ Millions)
Figure 14. Artemisinin Combination Therapy in Other
Figure 15. Global Artemisinin Combination Therapy Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Artemisinin Combination Therapy Market Size Market Share by Application in 2023
Figure 17. Global Artemisinin Combination Therapy Revenue Market Share by Player in 2023
Figure 18. Global Artemisinin Combination Therapy Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure 20. APAC Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure 21. Europe Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure 23. Americas Artemisinin Combination Therapy Value Market Share by Country in 2023
Figure 24. United States Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Artemisinin Combination Therapy Market Size Market Share by Region in 2023
Figure 29. APAC Artemisinin Combination Therapy Market Size Market Share by Type in 2023
Figure 30. APAC Artemisinin Combination Therapy Market Size Market Share by Application in 2023
Figure 31. China Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Artemisinin Combination Therapy Market Size Market Share by Country in 2023
Figure 38. Europe Artemisinin Combination Therapy Market Size Market Share by Type (2019-2024)
Figure 39. Europe Artemisinin Combination Therapy Market Size Market Share by Application (2019-2024)
Figure 40. Germany Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Artemisinin Combination Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 54. APAC Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 55. Europe Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 57. United States Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 58. Canada Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 61. China Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 62. Japan Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 63. Korea Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 65. India Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 66. Australia Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 67. Germany Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 68. France Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 69. UK Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 70. Italy Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 71. Russia Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 72. Spain Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 75. Israel Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Artemisinin Combination Therapy Market Size 2025-2030 ($ Millions)
Figure 78. Global Artemisinin Combination Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Artemisinin Combination Therapy Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Peptide Based Metabolic Disorders Therapeutics Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
November 2024
92 pages
Global Abdominal Aortic Aneurysm Treatment Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
September 2024
112 pages
Global Stainless Steel Cannula Market Growth 2025-2031
US$ 3,660.00
March 2025
165 pages
Global Huber Needles Market Growth 2024-2030
US$ 3,660.00
September 2024
115 pages
Global Veterinary Infusion Pumps Market Growth 2024-2030
US$ 3,660.00
September 2024
88 pages
